Aurdan Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Aurdan Capital Management's ABBV Position: Q3 2026 in Review
Aurdan Capital Management increased its AbbVie (ABBV) stake by 17% in Q3 2026, buying an estimated $39K and bringing the position to 1,028 shares worth $269K. The position accounts for 0.06% of the portfolio, ranked #99.
Aurdan Capital Management first reported a position in ABBV in Q3 2025 and has held it in 4 quarters since. 4,261 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Aurdan Capital Management held 1,028 shares of AbbVie worth $269K as of Q3 2026.
- Aurdan Capital Management bought 152 AbbVie shares in Q3 2026, an estimated $39K.
- AbbVie made up 0.06% of Aurdan Capital Management's portfolio in Q3 2026, its #99 holding.
- Aurdan Capital Management first reported a position in AbbVie in Q3 2025 and has held it in 4 quarters since.
- 4,261 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Aurdan Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.